Bellomo R, Ronco C, Kellum JA et al. (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Critical Care 8(4): R204–12

BioPorto, Instructions for use: The NGAL Test Reagent Kit Ref ST001CA. Available online at (last accessed 06/11/2013)

Cavalier E, Bekaert A-C, Carlisi A et al. (2011) Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite triage? The laboratory's point of view. Clinical Chemistry and Laboratory Medicine 49(2): 339–41

Cowland JB, Borregaard N (1997). Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45(1): 17–23

Dent CL, Ma Q, Dastrala S et al. (2007) Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Critical Care 11: R127

Di Nardo M, Ficarella A, Ricci Z et al. (2013) Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study. Blood Purification 35: 172–6

Grenier FC, Ali S, Syed H et al. (2010) Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clinical Biochemistry 43: 615–20

Health Service Journal Supplement on acute kidney injury. (2011) available at

Jeong T-D, Kim S, Lee W et al. (2012) Neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in liver transplantation. Clinical Transplantation 26: 775–81

KCAT, Chronic Kidney Disease (CKD) & eGFR. Available online at (last accessed 20/12/2013)

KDIGO (Kidney Disease Improving Global Outcomes). Clinical practice guideline for acute kidney injury, (2012). Kidney International Supplements Vol. 2, Issue 1.

Kift RL, Messenger MP, Wind TC et al. (2012) A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine. Annals of Clinical Biochemistry 50: 236–44

Levey AS, Coresh J, Greene T et al. (2007) Chronic kidney disease epidemiology collaboration. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical Chemistry 53: 766–72

Lippi G, Sanchis-Gomar F, Salvagno GL et al. (2012a) Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise. Clinical Chemistry and Laboratory Medicine 50(9): 1585–9

Lippi G, Aloe R, Storelli A et al. (2012b) Evaluation of NGAL Test, a fully-automated neutrophil gelatinase-associated lipocalin (NGAL) immunoassay on Beckman Coulter AU 5822. Clinical Chemistry and Laboratory Medicine 50(9): 1581–4

Mehta RL, Kellum JA, Shah SV et al. (2007) AKIN (Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury). Critical Care 11(2): R31

NICE (CG169) Acute kidney injury: Prevention, detection and management of acute kidney injury up the point of renal replacement therapy, (August 2013). National Institute for Health and Care Excellence.

Seo Y, Lee W, Hun Kwon O. (2013) Performance evaluation of BioPorto diagnostics' neutrophil gelatinase-associated lipocalin assay on automated clinical chemistry analyzer Hitachi 7600. Journal of Laboratory Medicine and Quality Assurance 35: 23–8

Shaw AD, Chalfin DB, Kleintjens J. (2011) The economic impact and cost-effectiveness of urinary neutrophil gelatinase-associated lipocalin after cardiac surgery. Clinical Therapeutics 33(11): 1713–25

Tsigou E, Vasiliki P, Demponeras C et al. (2013) Role of new biomarkers: Functional and structural damage. Critical Care Research and Practice, Article ID 361078, 13 pages.